Kafor Bernard Nonye Born on April 6, 1974, in Ehime Mbano, Imo State, Nigeria, K.A. For Bernard Nonye is a distinguished medical laboratory scientist and educator. He hails from Umuoparalum, Umualumaku, where he resides with his wife and three children. Bernard is a Nigerian citizen committed to diligence in human capacity development and efficiency in service delivery.
His academic journey began at Ishiagu Central School, Ebonyi State, where he earned his First School Leaving Certificate (FSLC) in 1988. He proceeded to Marist Comprehensive Academy, Uturu, Abia State, earning his Senior Secondary School Certificate (SSSC) in 1994. Bernard’s passion for medical sciences led him to the University of Nigeria, Enugu, where he obtained a Bachelor of Medical Laboratory Sciences (BMLS) degree in 2006. He furthered his education with a Master’s degree in Surgical Pathology from Abia State University in 2017 and a Ph.D. in Medical Laboratory Science (Histopathology) from the University of Nigeria, Enugu Campus, in 2024. Complementing his expertise, he earned a Diploma in Cytotechnology from the International Academy of Cytopathology in February 2023.
Bernard’s professional journey is illustrious, spanning several institutions. Since 2009, he has served as Chief Medical Laboratory Scientist at the Federal University Teaching Hospital, Owerri. He has also imparted knowledge as a part-time lecturer at Abia State University since 2017 and as a lecturer at Madonna University since 2023. Previously, he worked as a Histoscientist and slide demonstrator at Delta State University, Abraka (2008–2009), and as an intern at Nnamdi Azikiwe University Teaching Hospital, Nnewi (2007–2008). From 2014 to 2016, he was the Quality Manager for the Histopathology and Cytopathology Department at the Federal University Teaching Hospital, Owerri.
Bernard has participated in numerous training programs and conferences, including leadership and management courses for senior staff, immunohistochemistry training at the National Hospital Abuja, and multiple workshops organized by Eudoxia Research Centre, India. He has also attended specialized workshops on cytopathology and cellular pathology in Nigeria.
A dedicated researcher, Bernard has authored several publications in international journals, addressing topics such as reactive hyperplasia in lymph nodes, prostate disease diagnostics, breast cancer receptor profiling, and the modulatory effects of natural extracts on biochemical conditions. His recent works include studies on the histopathological effects of Annona muricata and Allium sativum extracts on prostate hyperplasia and cervical sampling techniques.
Bernard is an active member of various professional bodies, including the Association of Medical Laboratory Science Council of Nigeria (MLSCN), the Society of Cellular Pathology Scientists of Nigeria, and the International Academy of Cytology. His professional affiliations and extensive research contributions underscore his dedication to advancing medical science and education.
------
CERVICAL CANCER CYTOLOGY IN NIGERIA: CHALLENGES IN THE FACE OF WHO’S AGENDA 2030.
Cervical cancer is the fourth leading cause of cancer-related mortalities worldwide, causing the of over 231,000 women a year, with more than 80% of these deaths occurring in developing nations. There is geographical variation, in the distribution of the disease. In affluent nations with organized cervical screening, the disease has significantly decreased in comparison to those with little or no scheduled screening. The human papilloma virus is the primary causative agent of this illness, and treating it effectively may depend on early identification of the illness, its precursor cells, or the causative viral infection. Cervical cancer is second in Nigeria in terms of causes of mortality. The World Health Organization started a significant campaign to eradicate cervical cancer worldwide in 2020. With related intervention targets for 2030, the program is based on the three main pillars of cervical screening, treatment, and human papillomavirus (HPV) vaccine. Even before the goal year, the majority of rich nations are in a strong position to eradicate cervical cancer, but most underdeveloped nations still face challenges. Our purpose is to pinpoint issues that might naturally stand in the way of WHO's objectives being achieved in Nigeria. Reviews of academic publications on the topic found online can help achieve this. This study will identify the obstacles that may stand in Nigeria's way of accomplishing the WHO 2030 objectives and suggest potential remedies.